[Anticoagulant and antiatherosclerotic effects of 1-ethoxysilatrane].
Rasulov
M M
MM
Kuznetsov
I G
IG
Velikaia
M V
MV
Bartkova
L K
LK
Voronkov
M G
MG
D000818:Animals; D000925:Anticoagulants; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology; D001780:Blood Coagulation Tests; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002791:Cholesterol, Dietary / Q000009:adverse effects; D017646:Organosilicon Compounds; D011817:Rabbits; D012825:Silicon / Q000494:pharmacology*
D000925:Anticoagulants; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D002791:Cholesterol, Dietary; D017646:Organosilicon Compounds; C042292:1-ethoxysilatrane; D012825:Silicon
Antikoaguliantnye i antiateroskleroticheskie éffekty 1-étoksicilatrana.